Read the latest positive news, breakthroughs, and inspiring stories about epilepsy treatment, curated daily by BrightWire.
Scientists have created a tiny 3D-printed brain implant that both monitors seizures and stops them using targeted cooling, opening new doors for people with drug-resistant epilepsy. The breakthrough could transform treatment for patients who don't respond to medication.
A new pill designed for epilepsy just succeeded in treating bipolar mania with minimal side effects, offering hope for millions who struggle to stay on current medications. The unexpected win could reshape treatment options within two years.
Scientists discovered that calming an overactive immune pathway in the brain reduces seizures in mice with Dravet syndrome, a severe form of childhood epilepsy. The breakthrough could lead to new treatments for the one-third of epilepsy patients who don't respond to current medications.
A groundbreaking treatment for SYNGAP1, a rare genetic disease causing seizures and developmental delays, has entered human trials for the first time. The therapy aims to restore a crucial brain protein that 1,800 identified patients worldwide currently lack.
Researchers at Mayo Clinic have created a detailed map of a deep brain region that could help doctors precisely target therapies for people with drug-resistant epilepsy. The discovery shows that brain areas just 3 millimeters apart connect to completely different networks, providing a blueprint for more effective treatment.
An eight-month-old infant in Israel became the first person to receive groundbreaking gene therapy that restores missing brain function, potentially saving children from a devastating form of epilepsy. The treatment represents years of research turning into real hope for families facing ultra-rare genetic diseases.
Children with a devastating form of epilepsy may soon have new hope thanks to promising trial results from an experimental treatment. Praxis Precision Medicines announced their drug elsunersen successfully reduced seizures in early testing for SCN2A-related epilepsy.
University of Virginia researchers used gene editing to fix the DNA mutation causing a deadly form of epilepsy, potentially opening the door to cures for inherited brain disorders. The technique eliminated seizures in lab mice and improved their movement and cognitive function.
A breakthrough medication reduced seizures by 80% in children with a severe form of epilepsy, giving hope to thousands of families. The drug was well-tolerated by all 81 young patients in the trial.
A breakthrough treatment is transforming lives for children with Dravet syndrome, a severe form of epilepsy that can cause hundreds of seizures daily. Eight-year-old Freddie Truelove went from constant fits to just two seizures a week and is now skiing and climbing mountains.
A major pharmaceutical company just made epilepsy treatment more affordable for thousands of Americans. The new generic medication could slash costs for patients who rely on daily seizure prevention.